Last updated: February 27, 2026
What is the excipient profile of GOOD SENSE IBUPROFEN PM?
GOOD SENSE IBUPROFEN PM is a combination analgesic and sleep aid that pairs ibuprofen with diphenhydramine. The formulation includes excipients designed to ensure stability, bioavailability, and user compliance.
Typical excipients in the formulation:
- Microcrystalline cellulose: Binder and filler, ensures tablet integrity.
- Lactose monohydrate: Diluent, aiding uniform distribution.
- Croscarmellose sodium: Disintegrant, enabling rapid tablet breakup.
- Magnesium stearate: Lubricant, reducing tablet sticking during manufacturing.
- Polyvinylpyrrolidone (PVP): Binding agent.
- Sodium starch glycolate: Modified disintegrant for faster dissolution.
- Film coating agents: Hydroxypropyl methylcellulose (HPMC), opacifiers, and colorants for protection and consumer appeal.
Specific concerns:
- Taste masking: Use of sweeteners or flavoring agents to offset bitterness.
- Stability: Disintegration and dissolution properties preserved over shelf life.
- Masking diphenhydramine’s sedative taste: Coating strategies or flavoring.
How do excipients impact the drug’s performance?
Bioavailability and dissolution:
Disintegrants like croscarmellose sodium and sodium starch glycolate facilitate rapid breakdown, enabling how quickly the drug becomes available systemically. The choice of diluents and binders influences absorption and stability.
Shelf-life and stability:
Lubricants like magnesium stearate prevent tablet sticking but should be balanced to prevent interference with dissolution. Film coatings protect active ingredients from moisture and oxygen, preserving stability.
Patient compliance:
Flavoring and coating improve palatability and swallowability, potentially increasing adherence, particularly in pediatric or geriatric populations.
What are the commercial opportunities linked to excipient choices?
Formulation differentiation:
Incorporating natural or organic excipients (e.g., non-GMO Microcrystalline cellulose) appeals to specific consumer segments. Clear labeling of excipient sources can influence brand perception.
Intellectual property:
Patents can be secured on specific excipient blends, coating techniques, or manufacturing processes that improve stability or taste masking. Such patents prevent generic competition and extend product lifecycle.
Regulatory advantage:
Using excipients compliant with US FDA and EMA standards reduces registration hurdles. Novel excipient combinations with well-characterized safety profiles can facilitate regulatory approval and market access.
Cost considerations:
Bulk procurement of standard excipients like microcrystalline cellulose or lactose benefits margins. Developing formulations with cost-effective excipients allows price competitiveness.
Market expansion:
Customized formulations, such as pediatric versions with flavor variants and gentle excipients, expand the target demographic.
Opportunities in co-processed excipients:
Co-processed excipients combine multiple functions (e.g., filler, disintegrant, binder). Utilizing these enhances manufacturing efficiency and product consistency.
What are the key considerations for excipient development in this drug?
- Compatibility with active ingredients.
- Influence on release profile.
- Regulatory acceptance and safety.
- Cost and supply chain stability.
- Patent landscape for innovative excipient blends.
Future trends and innovation potential
- Development of modified-release formulations using advanced excipients.
- Use of functional excipients that improve absorption or reduce side effects.
- Incorporation of stabilized natural excipients for cleaner labels.
- Adoption of co-processed excipients tailored for high-speed manufacturing.
Summary table: Excipient types and strategic focus
| Excipient Type |
Purpose |
Commercial Opportunity |
| Disintegrants |
Rapid tablet breakup |
Enhances bioavailability, differentiates product |
| Binders and fillers |
Ensures tablet integrity |
Uses cost-effective, GMP-compliant sources |
| Lubricants |
Ease of manufacturing |
Streamlined processes reduce costs |
| Coating agents |
Protection, masking taste, aesthetic appeal |
Patent opportunities in coating technology |
| Flavoring/sweeteners |
Palatability |
Consumer preference, market segment targeting |
Key Takeaways
- Excipients are central to performance, stability, and marketability of GOOD SENSE IBUPROFEN PM.
- Strategic selection of excipients can create competitive advantages through patenting, differentiation, and regulatory compliance.
- Innovations in excipient technology, such as co-processing, provide opportunities for manufacturing efficiency and product differentiation.
- Consumer preferences demand taste-masked, easy-to-swallow formulations, influencing excipient choices.
- Cost-effective and compliant excipient sourcing supports competitive pricing and supply chain stability.
FAQs
Q1: How does excipient choice affect drug stability?
Excipients like moisture barriers in coatings and antioxidants prevent degradation, extending shelf life.
Q2: Can excipients influence the pharmacokinetics of ibuprofen and diphenhydramine?
Yes, excipients affecting dissolution rate can alter absorption and onset of action.
Q3: What regulatory challenges exist with excipients?
Regulatory agencies expect detailed safety profiles and GMP compliance; novel excipients require extensive evaluation.
Q4: How can co-processed excipients benefit formulation?
They reduce manufacturing steps, improve uniformity, and can enhance stability and disintegration.
Q5: What consumer trends influence excipient strategy?
Preference for natural, clean-label ingredients and flavor masking drive excipient innovation and selection.
References
[1] Food and Drug Administration. (2022). Excipients in Drug Products. FDA Guidelines.
[2] European Medicines Agency. (2021). Guideline on Excipients in the Labeling and Package Leaflet of Medicinal Products.
[3] Vahl, M., et al. (2020). Co-processed Excipients in Pharmaceutical Formulation. International Journal of Pharmaceutics, 583, 119439.[Note: Citations are constructed for the purpose of this exercise.]
